Suzhou Zelgen Biopharmaceuticals Co., Ltd. (SHA:688266)
85.50
-2.38 (-2.71%)
At close: Jan 22, 2026
SHA:688266 Market Cap
SHA:688266 has a market cap or net worth of 23.26 billion as of January 22, 2026. Its market cap has increased by 41.58% in one year.
Market Cap
23.26B
Enterprise Value
22.30B
Revenue
742.28M
Ranking
n/a
PE Ratio
n/a
Stock Price
85.50
Market Cap Chart
Since January 23, 2020, SHA:688266's market cap has increased from 17.90B to 23.26B, an increase of 29.95%. That is a compound annual growth rate of 4.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 23.26B | -5.20% |
| Dec 31, 2025 | 24.54B | 48.77% |
| Dec 31, 2024 | 16.49B | 17.70% |
| Dec 29, 2023 | 14.01B | 40.02% |
| Dec 30, 2022 | 10.01B | -29.08% |
| Dec 31, 2021 | 14.11B | -9.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 23, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 406.83B |
| WuXi AppTec | 311.06B |
| Shenzhen Mindray Bio-Medical Electronics | 242.11B |
| Sichuan Biokin Pharmaceutical | 126.75B |
| Shanghai United Imaging Healthcare | 110.18B |
| Aier Eye Hospital Group | 105.78B |
| Zhangzhou Pientzehuang Pharmaceutical., | 101.25B |
| Yunnan Baiyao Group Co.,Ltd | 100.31B |